← Eichor
Study identifier: NCT05408117 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Impact of Suture Type on Pigment Disturbances in Patients of Skin of Color

Condition: Scar  ·  Sponsor: Melissa Pugliano-Mauro

PhaseNA
Planned participants34
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The present study assesses if dissolvable (fast gut) or non-dissolvable (polypropylene) epidermal sutures produce better cosmetic results in terms of dyspigmentation and scarring in patients of skin of color. Through a split-wound study design, patients undergoing standard elliptical excisions at least 3 cm in length will receive each suture type. Measurements of dyspigmentation and scarring will be made at 7 days (for the head and neck), 10 days (for the trunk and extremities), and 3 months for all locations.

This description comes directly from the study's public registry record.

Talk to the study team

Melissa Pugliano-Mauro, MD  ·  412-784-7350  ·  puglianomauroma@upmc.edu

Jeffrey M Plowey, MS, ASCP(HTL)  ·  412-784-7350  ·  ploweyjm2@upmc.edu

Always discuss trial participation with your own doctor first.

Locations (3)

UPMC PresbyterianPittsburgh, Pennsylvania, United StatesRecruiting
UPMC St. MargaretPittsburgh, Pennsylvania, United StatesRecruiting
UPMC Shadyside PlacePittsburgh, Pennsylvania, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05408117